NIVFNewGenIvf Group Limited

$13980

Q4 2024 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$1M-16.2% YoY

Gross Profit

$359,43328.2% margin

Operating Income

-$1M-85.5% margin

Net Income

-$108,000-8.5% margin

EPS (Diluted)

$-23.75

QoQ Revenue Growth

-13.5%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4M

Total Liabilities

$5M

Stockholders' Equity

-$844,614

Cash & Equivalents

$457,740

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-16.2%
Gross Profit	$359,433	$196,825	+82.6%
Operating Income	-$1M	-$1M	+14.0%
Net Income	-$108,000	-$955,000	+88.7%

NIVF Q4 2024 Earnings — NewGenIvf Group Limited Revenue & Financial Results | Market Cap Arena